GINMU >

ブラウズ : 主題 Liver fibrosis

発行日	タイトル	著者
2024年9月	Cabozantinib prevents the progression of metabolic dysfunction-associated steatohepatitis by inhibiting the activation of hepatic stellate cell and macrophage and attenuating angiogenic activity	Matsuda, Takuya; Kaji, Kosuke; Nishimura, Norihisa; Asada, Shohei; Koizumi, Aritoshi; Tanaka, Misako; Yorioka, Nobuyuki; Tsuji, Yuki; Kitagawa, Koh; Sato, Shinya; Namisaki, Tadashi; Akahane, Takemi; Hitoshi, Yoshij
2021年12月28日火曜日	Dual therapy with zinc acetate and rifaximin prevents from ethanolinduced liver fibrosis by maintaining intestinal barrier integrity	Fujimoto, Yuki; Kaji, Kosuke; Nishimura, Norihisa; Enomoto, Masahide; Murata, Koji; Takeda, Soichi; Takaya, Hiroaki; Kawaratani, Hideto; Moriya, Kei; Namisaki, Tadashi; Akahane, Takemi; Yoshiji, Hitoshi
2024年7月	Effects of elafibranor on liver fibrosis and gut barrier function in a mouse model of alcohol-associated liver disease	Koizumi, Aritoshi; Kaji, Kosuke; Nishimura, Norihisa; Asada, Shohei; Matsuda, Takuya; Tanaka, Misako; Yorioka, Nobuyuki; Tsuji, Yuki; Kitagawa, Koh; Sato, Shinya; Namisaki, Tadashi; Akahane, Takemi; Yoshiji, Hitoshi
2016年12月	Ipragliflozin, a sodium-glucose cotransporter 2 inhibitor, ameliorates the development of liver fibrosis in diabetic Otsuka Long-Evans Tokushima fatty rats.	Nishimura, Norihisa; Kitade, Mitsuteru; Noguchi, Ryuichi; Namisaki, Tadashi; Moriya, Kei; Takeda, Kosuke; Okura, Yasushi; Aihara, Yosuke; Douhara, Akitoshi; Kawaratani, Hideto; Asada, Kiyoshi; Yoshiji, Hitoshi